Antios Therapeutics

Share on: 
Business Area(s): 

Antios Therapeutics is a clinical-stage biopharmaceutical company focused on the development of innovative therapies to treat and cure viral diseases. Our lead therapeutic candidate, ATI-2173, is a first-in-class Active Site Polymerase Inhibitor Nucleotide (ASPIN) that is in development as the backbone of an oral, once-daily potential curative therapy for HBV.

Atlanta GA
United States